Theranos plans massive Dx expansion in Arizona; Duke University spinoff raises cash to fuel quicker POC tests;

> California diagnostics company Theranos plans to expand to Scottsdale, AZ, and will hire 500 new people. Story

> The Broad Institute of MIT and Harvard received a $650 million donation for psychiatric research, money that will analyze genes responsible for diseases such as schizophrenia and bipolar disorder. Story | More from FierceBiotech

> Illumina ($ILMN) and Berry Genomics have agreed to develop a next-generation sequencing system that uses tech from both companies for review and approval in China. Item

> Duke University spinoff SenGenix raised $2.5 million toward development of a new way to enable quicker point-of-care diagnostics in the doctor's office. Story

> The New York City Economic Development Corp. is seeking VC partners to back diagnostics and med tech startups. Story

> Vivione Biosciences won certification for its new rapid E. coli diagnostic tests, which are designed to produce results within 7 hours or less. Release

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.